DAVID HAMMACK: Open Payments
NPI 1497006043 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 47 payments from 20 companies in 2025. Trend: 2023 $2,247 · 2024 $1,591 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $206 |
| Abbott Laboratories | 5 | $86 |
| PFIZER INC. | 3 | $50 |
| Insulet Corporation | 2 | $45 |
| Amgen Inc. | 3 | $44 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $30 |
Products named: FREESTYLE LIBRE 3, QULIPTA, UBRELVY, Omnipod, TRELEGY ELLIPTA, Kerendia, JARDIANCE, CAPLYTA.
Industry payments across NY — which companies pay providers there.
